Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9685328rdf:typepubmed:Citationlld:pubmed
pubmed-article:9685328lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:9685328lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:9685328lifeskim:mentionsumls-concept:C0038323lld:lifeskim
pubmed-article:9685328lifeskim:mentionsumls-concept:C0057738lld:lifeskim
pubmed-article:9685328lifeskim:mentionsumls-concept:C0220905lld:lifeskim
pubmed-article:9685328lifeskim:mentionsumls-concept:C0661253lld:lifeskim
pubmed-article:9685328lifeskim:mentionsumls-concept:C0764092lld:lifeskim
pubmed-article:9685328pubmed:issue32lld:pubmed
pubmed-article:9685328pubmed:dateCreated1998-9-10lld:pubmed
pubmed-article:9685328pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9685328pubmed:abstractTextDiazepam-binding inhibitor/acyl-CoA-binding protein (DBI/ACBP), a highly conserved 10-kDa polypeptide, has been implicated in various physiological processes including gamma-aminobutyric acid type A receptor binding, acyl-CoA binding and transport, steroidogenesis, and peptide hormone release. Both in LNCaP prostate cancer cells and 3T3-L1 preadipocytes, the expression of DBI/ACBP is stimulated under conditions that promote lipogenesis (treatment with androgens and insulin, respectively) and that involve the activation of sterol regulatory element-binding proteins (SREBPs). Accordingly, we investigated whether DBI/ACBP expression is under the direct control of SREBPs. Analysis of the human and rat DBI/ACBP promoter revealed the presence of a conserved sterol regulatory element (SRE)-like sequence. Gel shift analysis confirmed that this sequence is able to bind SREBPs. In support of the functionality of SREBP binding, coexpression of SREBP-1a with a DBI/ACBP promoter-reporter gene resulted in a 50-fold increase in transcriptional activity in LNCaP cells. Disruption of the SRE decreased basal expression and abolished SREBP-1a-induced transcriptional activation. In agreement with the requirement of a co-regulator for SREBP function, transcriptional activation by SREBP-1a overexpression was severely diminished when a neighboring NF-Y site was mutated. Cholesterol depletion or androgen treatment, conditions that activate SREBP function in LNCaP cells, led to an increase in DBI/ACBP mRNA expression and SRE-dependent transcriptional activation. These findings indicate that the promoter for DBI/ACBP contains a functional SRE that allows DBI/ACBP to be coregulated with other genes involved in lipid metabolism.lld:pubmed
pubmed-article:9685328pubmed:languageenglld:pubmed
pubmed-article:9685328pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9685328pubmed:citationSubsetIMlld:pubmed
pubmed-article:9685328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9685328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9685328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9685328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9685328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9685328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9685328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9685328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9685328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9685328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9685328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9685328pubmed:statusMEDLINElld:pubmed
pubmed-article:9685328pubmed:monthAuglld:pubmed
pubmed-article:9685328pubmed:issn0021-9258lld:pubmed
pubmed-article:9685328pubmed:authorpubmed-author:HeynsWWlld:pubmed
pubmed-article:9685328pubmed:authorpubmed-author:VerhoevenGGlld:pubmed
pubmed-article:9685328pubmed:authorpubmed-author:AldyDDlld:pubmed
pubmed-article:9685328pubmed:authorpubmed-author:SwinnenJ VJVlld:pubmed
pubmed-article:9685328pubmed:issnTypePrintlld:pubmed
pubmed-article:9685328pubmed:day7lld:pubmed
pubmed-article:9685328pubmed:volume273lld:pubmed
pubmed-article:9685328pubmed:ownerNLMlld:pubmed
pubmed-article:9685328pubmed:authorsCompleteYlld:pubmed
pubmed-article:9685328pubmed:pagination19938-44lld:pubmed
pubmed-article:9685328pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:meshHeadingpubmed-meshheading:9685328-...lld:pubmed
pubmed-article:9685328pubmed:year1998lld:pubmed
pubmed-article:9685328pubmed:articleTitleIdentification of diazepam-binding Inhibitor/Acyl-CoA-binding protein as a sterol regulatory element-binding protein-responsive gene.lld:pubmed
pubmed-article:9685328pubmed:affiliationLaboratory for Experimental Medicine and Endocrinology, Faculty of Medicine, Onderwijs en Navorsing, Gasthuisberg, Catholic University of Leuven, B-3000 Leuven, Belgium. johan.swinnen@med.kuleuven.ac.belld:pubmed
pubmed-article:9685328pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9685328pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9685328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9685328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9685328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9685328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9685328lld:pubmed